abstract |
The present invention provides parenteral formulations of rapamycin 42-ester containing 3-hydroxy-2- (hydroxymethyl) -2-methylpropionic acid (CCI-779). n n n 3-hydroxy-2- (hydroxymethyl) -2-methylpropionic acid (CCI-779), rapamycin 42-ester, parenteral formulation, streptomyces hygroscopicus, diluent solvent, antioxidant, surfactant |